Karapandzic, Vesna Miodrag (23469886900)Vesna Miodrag (23469886900)KarapandzicVujisic-Tesic, Bosiljka D. (6508177183)Bosiljka D. (6508177183)Vujisic-TesicPesko, Predrag M. (7004246956)Predrag M. (7004246956)PeskoNenadic, Brankica M. (8314478300)Brankica M. (8314478300)NenadicBabic, Dragan D. (7102518871)Dragan D. (7102518871)Babic2025-06-122025-06-122008https://doi.org/10.1016/j.jclinane.2007.12.014https://www.scopus.com/inward/record.uri?eid=2-s2.0-46449101726&doi=10.1016%2fj.jclinane.2007.12.014&partnerID=40&md5=194556b6f167b190aca6928dab799996https://remedy.med.bg.ac.rs/handle/123456789/10689Study Objective: To analyze the clinical effectiveness of the β-1-aderenergic blocker, metoprolol. Design: Prospective, observational, clinical study. Setting: Operating room and intensive care unit of a tertiary-care teaching hospital. Patients: 111 ASA physical status II, III, and IV consecutive patients who were scheduled for open abdominal nonvascular surgery. Interventions: Patients were divided into two stratification groups: 83 (74.8%) of 111 received metoprolol, and 28 (25.2%) of 111 were controls. Within 24 to 96 hours, the drug was used parenterally in a dose of 5, 10, and 15 mg per 24 hours. Metoprolol cardioprotection was applied during the whole perioperative period, in the form of tablets in a dose of 25, 50, and 100 mg per 24 hours until the 30th postoperative day. Measurements: During surgery, and in the first 72 postoperative hours, patients were monitored by continuous ST-T segment monitoring. A 12-lead electrocardiogram was attached immediately after surgery; on postoperative days 1, 2, and 7; and one day before discharge from the hospital. Serum troponin-T level was controlled 6, 24, and 96 hours after surgery. Main Results: Postoperative mortality of cardiac etiology after 30 days of surgery was 1.2% (1/83) in the metoprolol group versus 7.1% (2/28) in the nonmetoprolol group (P < 0.05). The causes of death in these three patients were acute myocardial infarction, congestive heart failure, and malignant arrhythmias. Conclusions: Perioperative cardioprotection significantly reduced mortality until postoperative day 30 in patients having open abdominal nonvascular surgery with general anesthesia. © 2008 Elsevier Inc. All rights reserved.β-BlockersMetoprololNoncardiac surgeryPerioperative cardiac complicationsPerioperative cardioprotection